Abstract Details

Title The Neurohospitalist. Key Performance Indicators. Experience in The American British Cowdray Medical Center, Centro Neurologico ABC in Mexico City

Topic Global Health

Presentation(s) P04 - (-)

Poster/Presentation
Number 233

Objective

Background BACKGROUND: The Hospitalist has been proven to maintain and increase the standards of quality and safety in health care systems. The results of incorporating a Hospitalist have impacted on reducing morbidity, increase hospital safety markers and impact in socioeconomic factors such as: length of stay, costs, early readmission rates and others markers.

Design/Methods DESIGN/METHODS: This is a retrospective cohort study using survey data from our center and applying only 5 important KPIs during 12 months/1000 patients vs same time/same number patients in two periods: preneurohospitalist and with aid of Neurohospitalist, between Sep 2009 and Sep 2011. The ABC Neurological Center is an institution with high expertise in Neurosciences part of the ABC Medical Center with international certification (JCI).

Results RESULTS: Five KPIs used were: 1) Mean length hospital stay. 2) Integration of the clinical chart. 3) Supervision of medical orders. 4) Early detection of risks and accidents during the hospital stay and 5) Satisfaction rates at hospital discharge and after it. . An Ad-hoc Committee evaluated all these markers in the two periods. Neurological and neurosurgical miscellaneous diagnoses were included for this evaluation. The results of the KPIs: 1 (5.2 vs 7.1 days, P <0.001), 2 (medium to high satisfaction vs poor integration record. 3 (high verification of medical orders vs poor check medical orders. 4) 1.5 vs 4.5 risks and accidents/month, p <0.001) and 5) high satisfaction rating vs median satisfaction.

Conclusions CONCLUSIONS: Strong evidences support the importance of having a Neurohospitalist as a member of a Neurological Center. It directly impact in preserve and maximize the quality and safety standards especially when the institutions are looking maintains the quality of international certification as by JCI.

Authors/Disclosures
Aurelio Mendez-Dominguez, MD (Instituto Nacional De Cardiologia Ignacio Chavez) PRESENTER	Dr. Mendez-Dominguez has nothing to disclose.
	No disclosure on file
	No disclosure on file
Marco A. Alegria Loyola, MD (ABC Medical Center Mexico)	No disclosure on file
	No disclosure on file
Manuel Ruiz Alvarez, MD (The American British Cowdray Medical Center)	No disclosure on file
	No disclosure on file
Ralf Gold, MD (Neurologische Universitaetsklinik)	Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.

��ɫ��

��ɫ��